52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience F.J. Melgosa Ramos, A. Mateu Puchades, J. Matáix-Díaz, L. Schneller-Pavelescu, I. Belinchón-Romero, S. Santos Alarcón

Sustained Efficacy of a Short Course of Upadacitinib in Atopic Dermatitis S. Córdoba, A. Martínez-Lauwers Dolz, AA. Garrido-Ríos, J. Borbujo

Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study J. Naharro-Rodríguez, E. Berná-Rico, F.J. Pérez-Bootello, B. Pérez-García